Bookedited by Ranjita Shegokar, Eliana B. Souto.
Summary: Emerging Nanotechnologies in Immunology: The Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanopharmaceuticals currently in the pipeline of S&T development for skin, ocular and nasal drug delivery, including absorption, toxicity, and the ability to distribute after systemic exposure. The book's contributors address a representative set of the broad spectrum of nanopharmaceutics presently being used, including cationic lipid nanoparticles, polymeric PLGA, PLA nanoparticles, biomacromolecules-based nanoparticles, and other scaffolds tissue-engineered skin substitutes. In addition, regulation and risk are also covered since the safety of these nanopharmaceuticals still represents a barrier to their wide and innovative use.
Contents:
1. Nanopharmceuticals in immunology: what's new in research?
2. Skin delivery of antimicrobial peptides
3. Skin penetration of nanoparticles
4. Regulatory and risk assessment perspective for core-multishell nanocarriers: a novel excipient on its way towards marketing authorization
5. Lipid nanoparticles as carriers for delivery of anti-inflammatory drugs
6. New strategies for the treatment of autoimmune diseases using nanotechnologies
7. Nanopharmaceuticals: application in inhaler systems
8. Immunomodulatory effects of curcumin in infectious and non infectious diseases
9. Advances in antibiotic nanotherapy: overcoming antimicrobial resistance
Index.